companydata.dkACESION PHARMA ApS: Financial statements 2018
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -18,647,333 and a net result of DKK -25,088,392 compared with DKK -23,972,490 the year before. Equity amounted to DKK -6,495,952. The company had 10 employees in the financial year.
- Gross Profit
- -18,647,333 kr.
- Profit/Loss
- -25,088,392 kr.
- Equity
- -6,495,952 kr.
- Total Assets
- 29,378,954 kr.
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -18.6 mio. | -25.1 mio. | -6.5 mio. | 10 |
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
| 2016 | - | -14.4 mio. | -18.3 mio. | 14.1 mio. | - |
| 2015 | - | -8.5 mio. | -9.8 mio. | 1.5 mio. | - |
| 2014 | - | -4.7 mio. | -6.5 mio. | 3.8 mio. | - |
Keep an eye on ACESION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of December 1, 2018, Torgeir Vaage is registered as director of ACESION PHARMA ApS.
As of December 1, 2018, Jakob Dynnes Hansen has stepped down as director of ACESION PHARMA ApS.
As of October 22, 2018, Ann Mills-Duggan has joined the board of directors of ACESION PHARMA ApS.
As of August 31, 2018, Georgios Trichas has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -17,450,508, and the net result was DKK -23,972,490.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.